97 related articles for article (PubMed ID: 7961004)
21. Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas.
Gentile MS; Usman AA; Neuschler EI; Sathiaseelan V; Hayes JP; Small W
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):257-65. PubMed ID: 26383674
[TBL] [Abstract][Full Text] [Related]
22. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
23. What is the best position of the arms in mantle field for Hodgkin's disease?
Pergolizzi S; Settineri N; Gaeta M; Scribano E; Santacaterina A; Ascenti G; Frosina P; de Renzis C
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):119-22. PubMed ID: 10656382
[TBL] [Abstract][Full Text] [Related]
24. An alternative mantle irradiation technique using 3D CT- based treatment planning for female patients with Hodgkin's disease.
Vuong T; Parker W; Patrocinio HJ; Fava P; Parmar D; Evans MD; Freeman CR
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):739-48. PubMed ID: 10837959
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle-enhanced MRI to evaluate radiation delivery to the regional lymphatics for patients with breast cancer.
MacDonald SM; Harisinghani MG; Katkar A; Napolitano B; Wolfgang J; Taghian AG
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1098-104. PubMed ID: 19836160
[TBL] [Abstract][Full Text] [Related]
26. A systematic study of posterior cervical lymph node irradiation with electrons: Conventional versus customized planning.
Jankowska PJ; Kong C; Burke K; Harrington KJ; Nutting C
Radiother Oncol; 2007 Oct; 85(1):132-7. PubMed ID: 17470378
[TBL] [Abstract][Full Text] [Related]
27. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast.
Goodman RL; Grann A; Saracco P; Needham MF
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):99-105. PubMed ID: 11316551
[TBL] [Abstract][Full Text] [Related]
28. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
30. Value of lymphangiography in the staging of Hodgkin lymphoma.
Libson E; Polliack A; Bloom RA
Radiology; 1994 Dec; 193(3):757-9. PubMed ID: 7972819
[TBL] [Abstract][Full Text] [Related]
31. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
32. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
Baumann BC; Guzzo TJ; He J; Vaughn DJ; Keefe SM; Vapiwala N; Deville C; Bekelman JE; Tucker K; Hwang WT; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):363-9. PubMed ID: 22658217
[TBL] [Abstract][Full Text] [Related]
33. Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique.
Zunino S; Rosato O; Lucino S; Jauregui E; Rossi L; Venencia D
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):53-9. PubMed ID: 10219794
[TBL] [Abstract][Full Text] [Related]
34. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies.
Chao KS; Lin M
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1147-52. PubMed ID: 12419442
[TBL] [Abstract][Full Text] [Related]
35. Advantages of CT and beam's eye view display to confirm the accuracy of pelvic lymph node irradiation in carcinoma of the prostate.
Forman JD; Lee Y; Roberson P; Montie JE; Zingas AP; Porter AT
Radiology; 1993 Mar; 186(3):889-92. PubMed ID: 8430203
[TBL] [Abstract][Full Text] [Related]
36. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation.
Wasserman TH; Trenkner DA; Fineberg B; Kucik N
Cancer; 1991 Sep; 68(6):1208-15. PubMed ID: 1873772
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
38. How iliopelvic lymphoscintigraphy can affect the definition of planning target volume in radiation therapy of pelvic and testicular tumors.
Campostrini F; Gregianin M; Rampin L; Lonardi F; De Lucchi A; Coeli M; Gioga G; Prina M; Ferretti G; Povolato M
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1303-13. PubMed ID: 12128133
[TBL] [Abstract][Full Text] [Related]
39. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
Müller AC; Eckert F; Paulsen F; Zips D; Stenzl A; Schilling D; Alber M; Bares R; Martus P; Weckermann D; Belka C; Ganswindt U
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):263-71. PubMed ID: 26853335
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
